Article Details
Retrieved on: 2024-10-07 08:05:56
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Microbiotica, a biopharma company, conducting trials for MB097, a microbiome treatment combined with the checkpoint inhibitor pembrolizumab, in treating melanoma. It aligns with the key concept 'biopharma' and tags like cancer immunotherapy.
Article found on: uk.finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here